Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...

In a report released today, Eric Serotta from Morgan Stanley maintained a Hold rating on Altria Group (MO – Research Report), with a price ...

Discover why Altria may be a strong investment opportunity, with potential for significant total returns and a possible ...

Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Altria Group (NYSE:MO) with a Equal-Weight ...

Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...

Altria Group, Inc. (MO), headquartered in Richmond, Virginia, is a leading producer and seller of smokeable and oral tobacco ...

Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming ...

The Food and Drug Administration authorized the marketing of 20 Zyn nicotine pouch products through the premarket tobacco product application ...

Signal Advisors Wealth LLC lessened its stake in shares of Altria Group, Inc. (NYSE:MO – Free Report) by 22.2% during the 4th ...

The U.S. Food and Drug Administration (FDA), which regulates products containing ... engine of large tobacco companies like British American Tobacco and Marlboro-maker Altria.

Harbor Capital Advisors Inc. grew its position in Altria Group, Inc. (NYSE:MO – Free Report) by 2.3% in the 4th quarter, ...

Altria Group, founded in 1822, manufactures and sells cigarettes, smokeless tobacco products, and alcoholic beverages in the United States and abroad. Its wholly owned subsidiaries include Philip ...